Saturday 17 October 2026 Export BVS’s income statement to Excel — free account

Bioventus Inc.

Bioventus Inc.’s revenue for fiscal 2025 (year ended December 2025) was $568.1 million, down 0.91% from fiscal 2024. In the quarter to June 2026, revenue grew 3.76%, EPS grew 345.5%, free cash flow fell 25.1% and total debt fell 27.2%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

13.30 0.51 −3.69%

Follow BVS

Alert me

Market cap: $1.2B
P/E: 16.4×
Fwd P/E: 21.4×
Dividend yield: —
F-score: 8/9
Altman Z: 1.26
Beneish M: −2.77
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Bioventus Inc. (BVS) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Bioventus Inc. (BVS) trades at a P/E ratio of 16.4×. Over the past ten years it has ranged from 0.0× (September 2025) to 64.9× (November 2025); the current reading is higher than 79% of that period. That is below the Medical Devices industry median of 23.2× and below the Healthcare sector median of 23.0×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BVS/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Bioventus Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BVS/metrics/pe-ratio">Bioventus Inc. (BVS) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	21.9×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	32.4×	47.97%
FY2020	21.9×	0.00%
FY2019	21.9×	0.00%
FY2018	21.9×	0.00%
FY2017	21.9×	0.00%
FY2016	21.9×	—

Period	P/E ratio	Change
Jun 2026	11.7×	(45.11%)
Mar 2026	21.2×	(2.97%)
Dec 2025	21.9×	(60.75%)
Sep 2025	55.8×	—
23 more quarters	Free account

Against its own ten years

Low 0.0× High 64.9×

Ten-year median 0.0×

Current reading's percentile 79

Company	P/E ratio
AORT Artivion, Inc. compare	n/m
CBLL CeriBell, Inc. compare	n/m
IART Integra LifeSciences Holdings Corporation compare	n/m
ENOV Enovis Corporation compare	n/m
TNDM Tandem Diabetes Care, Inc. compare	n/m
PRCT PROCEPT BioRobotics Corporation compare	n/m
LMRI Lumexa Imaging Holdings, Inc. compare	n/m
BVS Bioventus Inc.	16.4×
IRMD iRadimed Corporation compare	48.5×
Medical Devices industry median	23.2×
Healthcare sector median	23.0×
Market median	18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Bioventus Inc. (BVS) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on BVS

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on BVS

Stockrow Weekly